Moderna improves forecast for 2022 sales from COVID-19 vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AVGO
5. AAPL
6. ALNY
7. CNS
8. STLA
9. EC
10. SRE

Go back to Moderna improves forecast for 2022 sales from COVID-19 vaccine
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 140.34 +2.35 (1.70%)
Previous Close $137.99    52 Week High $0.52 
Open $134.10    52 Week Low $0.08 
Day High $144.20    P/E N/A 
Day Low $133.86    EPS $-3.80 
Volume 18,573,058